Saman Ghaffari, DO
Physical Medicine & Rehabilitation · Avon, OHNPI 1134245913
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $3,000 of the $4,099 with a category attached, or 73.2%. AbbVie accounts for 98.1% of it on its own, with 3 other manufacturers making up the rest. Among physical medicine & rehabilitation clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 12 payments — averaging $341.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Merz North America, Inc.$46
- Acadia Pharmaceuticals Inc$15
- Medline Industries LP$15
What the payments were for
- Speaking & faculty fees$3,00073%
- Travel & lodging$70317%
- Food & beverage$39610%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 8 | $4,022 |
| Merz North America, Inc. | 2 | $46 |
| Acadia Pharmaceuticals Inc | 1 | $15 |
| Medline Industries LP | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$3,833
How this compares
$4,099 in reported general payments places this provider in the 90th percentile of 332 physical medicine & rehabilitation providers in Ohio.
See all physical medicine & rehabilitation providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 330 | $108,705 |
| JardianceEmpagliflozin | 39 | $15,667 |
| JanuviaSitagliptin Phosphate | 35 | $10,023 |
| TrulicityDulaglutide | 18 | $10,022 |
| XareltoRivaroxaban | 21 | $7,629 |
| MyrbetriqMirabegron | 33 | $7,386 |
| Levetiracetam | 114 | $5,288 |
| Atorvastatin Calcium | 361 | $5,106 |
| Memantine Hcl | 91 | $4,157 |
| Pantoprazole Sodium | 214 | $3,837 |
| Rasagiline Mesylate | 19 | $3,633 |
| Gabapentin | 180 | $3,127 |
| Midodrine Hcl | 25 | $3,074 |
| Divalproex Sodium | 50 | $2,817 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 18 | $2,293 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Avon
- Claire CooperAvon$22K
- Steven KimAvon$6K
- Andrew GoldblumAvon$3K
- Michael BariaLewis Center$175K
- Kathryn MosherAkron$121K
- Marc OrlandoCincinnati$114K
- Aileen PadillaPerrysburg$73K
- Jeffrey StrakowskiColumbus$59K
- Kurt KuhlmanLima$46K
- Francois BethouxCleveland$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.